Cargando…
Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review
Background: Polycystic ovary syndrome (PCOS) is a chronic disorder and is one of the most common endocrine disorders in women of a reproductive age. The prevalence of PCOS is growing globally; 52% of women in Southeast Asia alone suffer from this disorder. This disorder is caused by chronic hyperand...
Autores principales: | Prayitno, Gunawan Dwi, Lestari, Keri, Sartika, Cynthia Retna, Djuwantono, Tono, Widjaya, Andi, Muharam, R., Hidayat, Yudi Mulyana, Wulandari, Dewi, Haifa, Rima, Naura, Nabilla Farah, Marbun, Kristin Talia, Zahrah, Annisah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864810/ https://www.ncbi.nlm.nih.gov/pubmed/36662487 http://dx.doi.org/10.3390/medicines10010003 |
Ejemplares similares
-
Correlation of Serum Anti-Mullerian Hormone (AMH) Level on Ovarian Volume in Women with Endometrioma
por: Suardi, Dodi, et al.
Publicado: (2021) -
Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients
por: Hidayat, Yudi Mulyana, et al.
Publicado: (2020) -
Interleukins Profiling in Umbilical Cord Mesenchymal Stem Cell-Derived Secretome
por: Chouw, Angliana, et al.
Publicado: (2022) -
Exosomes/EVs: CASE SERIES: THE COMBINATION OF RECOMMENDED TREATMENT PROTOCOLS WITH ADD-ON SECRETOME FROM UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS (UC-MSCS) THERAPY AS A MEDICAL STRATEGY FOR COVID-19 TREATMENT
por: Adhiarta, A., et al.
Publicado: (2022) -
Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19
por: Chouw, Angliana, et al.
Publicado: (2021)